Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity

Tae Woo Kim, Young Lee Tae, Cheol Bae Hyun, Ho Hahm Jeong, Hyun Kim Yang, Chung Park, Heung Kang Tae, Joong Kim Chul, Hee Sung Moon, Haryoung Poo

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.

Original languageEnglish
Pages (from-to)775-780
Number of pages6
JournalJournal of Immunology
Volume179
Issue number2
Publication statusPublished - 2007 Jul 15

Fingerprint

Prostaglandins A
Cellular Immunity
Natural Killer Cells
Oral Administration
Glutamic Acid
Glucans
Inbred C57BL Mouse
Neoplasms
Bacillus subtilis
Tumor Cell Line
Knockout Mice
Immunity

ASJC Scopus subject areas

  • Immunology

Cite this

Kim, T. W., Tae, Y. L., Hyun, C. B., Jeong, H. H., Yang, H. K., Park, C., ... Poo, H. (2007). Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. Journal of Immunology, 179(2), 775-780.

Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. / Kim, Tae Woo; Tae, Young Lee; Hyun, Cheol Bae; Jeong, Ho Hahm; Yang, Hyun Kim; Park, Chung; Tae, Heung Kang; Chul, Joong Kim; Moon, Hee Sung; Poo, Haryoung.

In: Journal of Immunology, Vol. 179, No. 2, 15.07.2007, p. 775-780.

Research output: Contribution to journalArticle

Kim, TW, Tae, YL, Hyun, CB, Jeong, HH, Yang, HK, Park, C, Tae, HK, Chul, JK, Moon, HS & Poo, H 2007, 'Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity', Journal of Immunology, vol. 179, no. 2, pp. 775-780.
Kim, Tae Woo ; Tae, Young Lee ; Hyun, Cheol Bae ; Jeong, Ho Hahm ; Yang, Hyun Kim ; Park, Chung ; Tae, Heung Kang ; Chul, Joong Kim ; Moon, Hee Sung ; Poo, Haryoung. / Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity. In: Journal of Immunology. 2007 ; Vol. 179, No. 2. pp. 775-780.
@article{66459b694414410d94199a95b642797a,
title = "Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity",
abstract = "We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.",
author = "Kim, {Tae Woo} and Tae, {Young Lee} and Hyun, {Cheol Bae} and Jeong, {Ho Hahm} and Yang, {Hyun Kim} and Chung Park and Tae, {Heung Kang} and Chul, {Joong Kim} and Moon, {Hee Sung} and Haryoung Poo",
year = "2007",
month = "7",
day = "15",
language = "English",
volume = "179",
pages = "775--780",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "2",

}

TY - JOUR

T1 - Oral administration of high molecular mass poly-γ-glutamate induces NK cell-mediated antitumor immunity

AU - Kim, Tae Woo

AU - Tae, Young Lee

AU - Hyun, Cheol Bae

AU - Jeong, Ho Hahm

AU - Yang, Hyun Kim

AU - Park, Chung

AU - Tae, Heung Kang

AU - Chul, Joong Kim

AU - Moon, Hee Sung

AU - Poo, Haryoung

PY - 2007/7/15

Y1 - 2007/7/15

N2 - We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.

AB - We analyzed the in vivo tumor regression activity of high molecular mass poly-γ-glutamate (γ-PGA) from Bacillus subtilis sups. chungkookjang. C57BL/6 mice were orally administered 10-, 100-, or 2000-kDa γ-PGA or β-glucan (positive control), and antitumor immunity was examined. Our results revealed higher levels of NK cell-mediated cytotoxicity and IFN-γ secretion in mice treated with higher molecular mass γ-PGA (2000 kDa) vs those treated with lower molecular mass γ-PGA (10 or 100 kDa) or β-glucan. We then examined the effect of oral administration of 10- or 2000-kDa γ-PGA on protection against B16 tumor challenge in C57BL/6 mice. Mice receiving high molecular mass γ-PGA (2000 kDa) showed significantly smaller tumor sizes following challenge with the MHC class I-down-regulated tumor cell lines, B16 and TC-1 P3 (A15), but not with TC-1 cells, which have normal MHC class I expression. Lastly, we found that γ-PGA-induced antitumor effect was decreased by in vivo depletion of NK cells using mAb PK136 or anti-asialo GM1 Ab, and that was completely blocked in NK cell-deficient B6 beige mice or IFN-γ knockout mice. Taken together, we demonstrated that oral administration of high molecular mass γ-PGA (2000 kDa) generated significant NK cell-mediated antitumor activity in mice bearing MHC class I-deficient tumors.

UR - http://www.scopus.com/inward/record.url?scp=34548759204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548759204&partnerID=8YFLogxK

M3 - Article

VL - 179

SP - 775

EP - 780

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 2

ER -